Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 2452: ONO-4059, a novel oral Bruton's tyrosine kinase (Btk) inhibitor that demonstrates potent pharmacodynamic activity through Phosphorylated Btk (P-Btk) inhibition, in addition to effective anti-tumour activity in a TMD-8 (DLBCL) xenograft model.

Cancer Res (2013) 73 (8_Supplement): 2452.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Yu Xue
  • Peiran Song
  • Zilan Song
  • Aoli Wang
  • Linjiang Tong
  • Meiyu Geng
  • Jian Ding
  • Qingsong Liu
  • Liping Sun
  • Hua Xie
  • Ao Zhang
Journal of Medicinal Chemistry (2018) 61 (10): 4608.
  • Candida Vitale
  • Valentina Griggio
  • Maria Todaro
  • Chiara Salvetti
  • Mario Boccadoro
  • Marta Coscia
Expert Opinion on Pharmacotherapy (2017) 18 (4): 411.
  • Christian Klein
  • Marina Bacac
  • Pablo Umana
  • Günter Fingerle-Rowson
Expert Opinion on Investigational Drugs (2017) 26 (10): 1145.
  • Pawel Robak
  • Tadeusz Robak
Expert Opinion on Investigational Drugs (2017) 26 (11): 1249.
  • Jingjing Wu
  • Christina Liu
  • Stella T. Tsui
  • Delong Liu
Journal of Hematology & Oncology (2016) 9 (1)
Close Modal

or Create an Account

Close Modal
Close Modal